Product
mRNA-1273.231
1 clinical trial
1 indication
Indication
COVID-19Clinical trial
A Phase 2/3 Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 VariantsStatus: Completed, Estimated PCD: 2023-11-17
1 clinical trial
1 indication